Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia | New England Journal of Medicine

This course meets the educational training criteria for the new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners. You will receive 48 annual print issues including: NEJM 高水平临床研究培训认证项目 Subscribe or Renew Subscribe or Renew See more details Select the format you want to export the citation of this publication. https://www.nejm.org/doi/10.1056/NEJMoa1301689 Copied! Copying failed. Characterization of Mutations.Panel A shows the numbers of verified, recurrent tier 1 mutations in each of 200 samples obtained from patients with AML, organized according to important cytogenetic and mutational findings. For each set of data, the middle horizontal line indicates the mean, and the shaded area indicates ±1 SD. P values are shown for the groups that had significant differences from the mean number of recurrent tier 1 mutations in all samples. NK denotes normal karyotype. Panel B shows significantly mutated genes, as identified

saved by

• Gem Wu